Maze Therapeutics, Inc. ($MAZE)
Filing Information
| Accession Number | 0002050172-26-000013 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 3, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
72,000
Total Value
$0.00
P&L
+inf% (+$3,458,160.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
President, R&D & CMO | Stock Option (Right to Buy) | Derivative | Mar 2, 2026 | Grant/Award | 48,000 | $0.00 | $0.00 | 48,000 | Direct | โ | View Details | |
President, R&D & CMO | Restricted Stock Units | Derivative | Mar 2, 2026 | Grant/Award | 24,000 | $0.00 | $0.00 | 24,000 | Direct | โ | View Details |